TCL Archive In Brief: Morton Leaves UCLA Surgical Oncology; Rall Resigns As NIH Deputy for Intramural Research May 17, 1991
TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012